Discover the benefits of connected insulin delivery devices, like smart insulin pens, and the integrated data that they provide.

An overview of automated insulin delivery systems, including current data and practical tips for the DCES. This webinar will use a case study approach and review published research on the psychosocial considerations for users of this technology.

This presentation will teach basic concepts of insulin pump therapy and continuous glucose monitoring for those who are new to the field or those who don't work with technology on a regular basis and are looking for a good overview or what is currently available.

In this session, speakers will discuss strategies for the diabetes care and education specialist to identify disparities and therapeutic inertia around diabetes technology using the Identify, Configure, Collaborate (ICC) framework.

Advances in technology offer new device choices such as insulin delivery devices, CGM and AID systems. This presentation will provide an update of what diabetes care and education specialists need to know about these new technologies, who will benefit most and what’s in the pipeline.

Some people with diabetes choose not to use an insulin pump due to factors such as cost, insurance coverage and complexity. This session will review other options for insulin delivery such as smart insulin pens, inhaled insulin and disposable insulin delivery.

This session will discuss the fundamental algorithms for automated insulin delivery that are employed for management of blood glucose and specific implementation choices that significantly affect user and provider experience.

This session will use case-based scenarios to illustrate the use of smart insulin pens and hybrid closed-loop systems and demonstrate how these devices ease data downloading for interpretation and shared decision making to optimize glycemic management.

This program will provide an update on currently available technology and its role in patient care as well as a look into what is expected to be FDA approved in the next 6-12 months.

Sponsored by CeQur, you will learn about a new bolus-only insulin patch that can be worn for up to 3 days and can be trained in about 15 minutes.

This course provides soup-to-nuts instruction and insight on all aspects of insulin pump therapy, from basics to advanced concepts.